Document is current
Any future updates will be listed below
-
Authors
Wischnewski, Vladimir https://orcid.org/0000-0002-9059-1304
Maas, Roeltje R.
Aruffo, Paola Guerrero
Soukup, Klara https://orcid.org/0000-0003-2764-4845
Galletti, Giovanni https://orcid.org/0000-0001-6613-2354
Kornete, Mara
Galland, Sabine
Fournier, Nadine https://orcid.org/0000-0002-9347-7929
Lilja, Johanna
Wirapati, Pratyaksha https://orcid.org/0000-0002-0327-4686
Lourenco, Joao
Scarpa, Alice
Daniel, Roy T.
Hottinger, Andreas F.
Brouland, Jean-Philippe
Losurdo, Agnese
Voulaz, Emanuele
Alloisio, Marco
Hegi, Monika E. https://orcid.org/0000-0003-0855-6495
Lugli, Enrico https://orcid.org/0000-0002-1964-7678
Joyce, Johanna A. https://orcid.org/0000-0002-6332-2598
- License Information
-
More Information
Article History
Received: 30 September 2022
Accepted: 19 April 2023
First Online: 22 May 2023
Competing interests
: M.E.H. has an advisory role at TME Pharma. E.L. receives research grants from Bristol Meyers Squibb on a topic unrelated to this manuscript. J.A.J. currently serves on the scientific advisory board of Pionyr Immunotherapeutics and received an honorarium for speaking at a research symposium organized by Bristol Meyers Squibb (last 3 years). All other authors have no competing interests.
